Frequently Asked Questions: CMS Waivers, Flexibilities, and the End of the COVID-19 Public Health Emergency

The Center for Medicare and Medicaid Services (CMS) provides answers to general and program-specific inquiries including Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and private insurance in an informative publication available here.

The following statement is from STLT Policy & Public Health Partnerships in regards to under 5 year old vaccinations:

On Saturday, June 18^th, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation to expand COVID-19 vaccination to children younger than 5 years of age. This decision now universally recommends COVID-19 vaccination for everyone 6 months and older, paving the way for about 20 million children in this age group to get vaccinated and allowing providers to begin vaccinating with either the Moderna or the Pfizer-BioNTech vaccine as soon as possible.

CDC releases "Rural Considerations for Vaccine Confidence and Uptake Strategies"

The Centers for Disease Control and Prevention has released another COVID-related rural resource that may be of interest. A “Rural Considerations” addendum was recently added to its field guide for conducting a Rapid Community Assessment (RCA). An RCA is a process for quickly collecting community insights about a public health issue in order to inform program design. The assessment involves reviewing existing data and conducting community-based interviews, listening sessions, observations, social listening, and surveys. In addition to the rural considerations addendum, the

The following information was an update made by the CDC on January 6, 2022: The CDC has updated guidance for K-12 schools to align with the updated quarantine and isolation guidance.

Quarantine is a strategy used to prevent transmission of COVID-19 by keeping people who have been in close contact with someone with COVID-19 apart from others. Isolation is used to separate people with confirmed or suspected COVID-19 from those without COVID-19.

Today the CDC Director issued two COVID-19 related recommendations following actions by the FDA:

• people who received the Pfizer-BioNTech COVID-19 Vaccine as their primary series are recommended to get a booster after 5 instead of 6 months
• moderately or severely immunocompromised 5–11-year-olds should receive an additional primary dose of the Pfizer-BioNTech COVID-19 vaccine 28 days after their second shot. 

The media statement released this morning is below.  The FDA action authorizing booster shots for children ages 12-15 will be discussed at an ACIP meeting scheduled for Jan 5.  When available,  we will communicate CDC’s decision. Providers are reminded to wait for the CDC recommendation before administering booster shots to this age group.